Review
Published on 17 Jul 2024
Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1413494
- 1,133 views
Type at least 3 characters
1,744 articles
Articles
Editorial
Published on 16 Jul 2024
Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1454837
- 740 views
Case Report
Published on 15 Jul 2024
Case report: 18F-FDG PET/CT skeletal superscan-like in an adult patient with acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1401453
- 756 views
Case Report
Published on 10 Jul 2024
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1390747
- 956 views
Mini Review
Published on 09 Jul 2024
“Off-The-Shelf” allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1433432
- 1,958 views
- 2 citations
Review
Published on 05 Jul 2024
Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1378647
- 2,354 views
- 2 citations
Mini Review
Published on 03 Jul 2024
Overview of infectious complications among CAR T- cell therapy recipients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1398078
- 2,186 views
- 1 citation
Original Research
Published on 02 Jul 2024
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1386670
- 1,197 views
Case Report
Published on 02 Jul 2024
Contrast-enhanced ultrasound findings of primary hepatic non-Hodgkin’s lymphoma: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1380392
- 794 views
Case Report
Published on 02 Jul 2024
The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402970
- 1,027 views
Original Research
Published on 01 Jul 2024
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1385987
- 1,072 views
Review
Published on 01 Jul 2024
Exploring treatment decision-making in chronic myeloid leukemia in chronic phase
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1369246
- 1,653 views
Review
Published on 01 Jul 2024
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1394057
- 1,575 views
Mini Review
Published on 28 Jun 2024
Treatment of AL amyloidosis in the era of novel immune and cellular therapies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1425521
- 2,214 views
- 1 citation
Original Research
Published on 25 Jun 2024
Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1376490
- 1,051 views
Mini Review
Published on 25 Jun 2024
Momelotinib – a promising advancement in the management of myelofibrosis in adults with anemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1411972
- 1,681 views